Last reviewed · How we verify

NCT04510883

Usage and Health Effects of Embodied Conversational Agents Among Older Adults

Completed NA Last updated 8 April 2021
What this trial tests

NA trial testing PACO in Eating Behavior in 52 participants. Completed in 30 December 2020.

Timeline
13 July 2020
Primary endpoint
30 December 2020
30 December 2020

Quick facts

Lead sponsorWageningen University and Research
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingsingle
Primary purposesupportive care
Enrollment52
Start date13 July 2020
Primary completion30 December 2020
Estimated completion30 December 2020
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Wageningen University and Research

Who can join

65 and older, any sex, with Eating Behavior or Loneliness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rationale: Embodied Conversational Agents (ECAs), could be a highly effective medium to address health behaviour change among older adults. As compliance to health advice is important for positive health outcomes, successful design of persuasive ECAs can have huge health benefits. However, insights in the mechanisms underlying usage and health behaviour change via ECAs are lacking. Objective: The objective is to unravel the mechanisms behind the use of an ECA intervention, and understand the mechanism behind the observed behaviour change Study design: A randomized staggered-entry waitlist-controlled trial will be carried out. Study population: The study population consist of Dutch-speaking older adults, who live independently, are without partner, are retired, 65+ and possess basic computer skills. Intervention: The application PACO has been created for (and with) older adults with the goal to motivate them to improve their eating behaviour and decrease their feelings of loneliness. Main study parameters/endpoints: The main study parameters are use, loneliness, and eating behaviour. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects are not exposed to any risks, nor have they any costs. They do have to fill in questionnaires and use the application. The duration and data collection moments are needed to gain a fine-grained understanding of the use, relationship development and health change process. For subjects, the main benefit is to gain insight in their health behaviour via the PACO-application. Although this might be experienced as confronting by some. The technology was developed based on sound theories, with input from the target group, so the investigators expect positive experiences and an improvement in participants loneliness and eating behaviour. However, this can only be proven after the study.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Use and Effect of Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Randomized Controlled Trial.
    Kramer LL, van Velsen L, Clark JL, Mulder BC, et al · · 2022 · cited 13× · PMID 35404255 · DOI 10.2196/33974
  2. Use and Effect of Web-Based Embodied Conversational Agents for Improving Eating Behavior and Decreasing Loneliness Among Community-Dwelling Older Adults: Protocol for a Randomized Controlled Trial.
    Kramer LL, Mulder BC, van Velsen L, de Vet E. · · 2021 · cited 9× · PMID 33404513 · DOI 10.2196/22186

Verify or expand the search:

Other recruiting trials for Eating Behavior

Currently open trials in the same condition.

Other Wageningen University and Research trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04510883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing